XML 19 R6.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Millions
 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Cash flows from operating activities:    
Cash receipts from customers $ 283,378 $ 264,538
Cash paid for inventory, prescriptions dispensed and health services rendered (157,849) (145,469)
Insurance benefits paid (88,769) (80,357)
Cash paid to other suppliers and employees (27,308) (28,933)
Interest and investment income received 1,494 1,288
Interest paid (2,529) (2,391)
Income taxes paid (1,168) (1,429)
Net cash provided by operating activities 7,249 7,247
Cash flows from investing activities:    
Proceeds from sales and maturities of investments 9,640 7,634
Purchases of investments (11,045) (12,677)
Purchases of property and equipment (2,048) (2,013)
Acquisitions (429) (85)
Other 9 75
Net cash used in investing activities (3,873) (7,066)
Cash flows from financing activities:    
Commercial paper borrowings (repayments), net (872) 600
Proceeds from issuance of long-term debt 3,969 4,959
Repayments of long-term debt (3,609) (1,706)
Repurchase of common stock 0 (3,023)
Dividends paid (2,552) (2,535)
Proceeds from exercise of stock options 308 342
Payments for taxes related to net share settlement of equity awards (145) (181)
Other (7) (22)
Net cash used in financing activities (2,908) (1,566)
Net increase (decrease) in cash, cash equivalents and restricted cash 468 (1,385)
Cash, cash equivalents and restricted cash at the beginning of the period 8,884 8,525
Cash, cash equivalents and restricted cash at the end of the period 9,352 7,140
Reconciliation of net income (loss) to net cash provided by operating activities:    
Net income (loss) (1,195) 2,963
Adjustments required to reconcile net income (loss) to net cash provided by operating activities:    
Depreciation and amortization 3,459 3,450
Goodwill impairment 5,725 0
Stock-based compensation 400 403
Loss on sale of subsidiary 236 0
Gain on deconsolidation of subsidiary (483) 0
Restructuring charges (impairment of long-lived assets) 0 840
Deferred income taxes and other items (440) (912)
Change in operating assets and liabilities, net of effects from acquisitions:    
Accounts receivable, net (7,537) (986)
Inventories (982) 355
Other assets (588) (850)
Accounts payable and pharmacy claims and discounts payable 5,052 2,169
Health care costs payable and other insurance liabilities 734 2,878
Other liabilities 2,868 (3,063)
Net cash provided by operating activities $ 7,249 $ 7,247